SA and India press for IP waiver for Covid-19 drugs at WTO
Opponents, including the EU, US and Switzerland, show little sign of budging
19 January 2021 - 21:21
Geneva — SA and India argued in favour of a waiver of intellectual property (IP) rights on Covid-19 drugs and vaccines at a closed-door meeting of the World Trade Organisation (WTO) on Tuesday but opponents showed little sign of budging, trade sources said.
Proponents of the temporary waiver as the pandemic continues to rage say that IP rules are hindering the urgent scale-up of Covid-19 vaccine production amid growing criticism of the inequitable distribution of shots...
BL Premium
This article is reserved for our subscribers.
A subscription helps you enjoy the best of our business content every day along with benefits such as articles from our international business news partners; ProfileData financial data; and digital access to the Sunday Times and Sunday Times Daily.
Already subscribed? Simply sign in below.
Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now